Agnieszka Bullmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Agnieszka Bullmann has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Ewelina Choroszewska
Śniadeckiego Voivodeship Hospital in Bialystok
7 shared publications - Artur Ciszewski
Independent Public Health Care Center in Sokolka
5 shared publications - Dominika Strzalińska
University Clinical Hospital In Bialystok: Bialystok
5 shared publications - Julia Bajko
Department of Urology and Oncological Urology, Faculty of Medicine, Medical University of Bialystok, Jana Kilinskiego 1, 15-089 Bialystok, Poland
5 shared publications - Julia Baran
University Clinical Hospital in Białystok, ul. M. C. Skłodowskiej 24a, 15-276 Białystok, Poland
5 shared publications - Juliusz Błażewicz
Dr Ludwik Rydygier Voivodeship Hospital in Suwalki
5 shared publications
Latest Publications
- Open Access
- 16 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 54
Botulinum Toxin Type A in the Treatment of Post-Stroke Spasticity - A Review of Current Evidence
Background: Post-stroke spasticity (PSS) affects up to 42% of stroke survivors and significantly impairs rehabilitation. Botulinum toxin type A (BoNT-A) is a first-line pharmacological treatment that reduces muscle overactivity by inhibiting acetylcholine release at the neuromuscular junction. Aim: To summarize the current evidence on BoNT-A therapy for PSS, with emphasis on mechanisms of action, optimal administration timing, injection guidance, dosing, safety, and functional outcomes, to inform individualized neurorehabilitation. Material and Methods: A literature search of PubMed was conducted to identify relevant studies on the efficacy and safety of BoNT-A in adult patients with PSS (2013–2026). Records were screened by title, abstract, and full text against predefined inclusion criteria. Results: BoNT-A effectively reduces PSS with Grade A evidence, with the greatest benefit when administered early (3–12 weeks post-stroke). Imaging- or electrophysiology-guided injections improve precision. Therapeutic effects are temporary (approximately 12 weeks), requiring repeated administration. Adverse events are mild and uncommon, supporting a favorable safety profile. Conclusions: BoNT-A is a safe and effective treatment for PSS, particularly when initiated early and guided by imaging or electrophysiological techniques. Its impact on functional recovery remains variable, highlighting the need for individualized treatment strategies integrated with comprehensive rehabilitation programs.
- 16 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 54
Open AccessBotulinum Toxin Type A in the Treatment of Post-Stroke Spasticity - A Review of Current Evidence
Background: Post-stroke spasticity (PSS) affects up to 42% of stroke survivors and significantly impairs rehabilitation. Botulinum toxin type A (BoNT-A) is a first-line pharmacological treatment that reduces muscle overactivity by inhibiting acetylcholine release at the neuromuscular junction. Aim: To summarize the current evidence on BoNT-A therapy for PSS, with emphasis on mechanisms of action, optimal administration timing, injection guidance, dosing, safety, and functional outcomes, to inform individualized neurorehabilitation. Material and Methods: A literature search of PubMed was conducted to identify relevant studies on the efficacy and safety of BoNT-A in adult patients with PSS (2013–2026). Records were screened by title, abstract, and full text against predefined inclusion criteria. Results: BoNT-A effectively reduces PSS with Grade A evidence, with the greatest benefit when administered early (3–12 weeks post-stroke). Imaging- or electrophysiology-guided injections improve precision. Therapeutic effects are temporary (approximately 12 weeks), requiring repeated administration. Adverse events are mild and uncommon, supporting a favorable safety profile. Conclusions: BoNT-A is a safe and effective treatment for PSS, particularly when initiated early and guided by imaging or electrophysiological techniques. Its impact on functional recovery remains variable, highlighting the need for individualized treatment strategies integrated with comprehensive rehabilitation programs.
- Open Access
- 5 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 53, 70252
Depression and Anxiety as Aspects of Mental Health in Celiac Disease: A Systematic Review and Meta-Analytical Synthesis
Background:Celiac disease (CD) is a chronic immune-mediated disorder with significant extraintestinal manifestations, including neuropsychiatric symptoms. Depression and anxiety are among the most frequently reported and may substantially affect quality of life. Aim:This review aimed to evaluate the prevalence of depressive and anxiety symptoms in adults and children with CD and to assess the influence of adherence to a GFD on psychiatric outcomes. Material and Methods:A structured narrative review with meta-analytical synthesis was conducted using studies identified through PubMed/MEDLINE, Scopus, and Web of Science. Observational studies, clinical cohorts, and existing meta-analyses were included. Findings were integrated narratively, considering age, disease status, and dietary adherence. Results:Depressive symptoms were consistently more prevalent in individuals with CD, particularly in untreated or newly diagnosed patients. Partial improvement was observed following initiation of a gluten-free diet although symptoms often persisted. Findings regarding anxiety were heterogeneous. Psychiatric outcomes were influenced by disease activity, age, nutritional status, and psychosocial factors. Conclusions:Depression and anxiety are clinically relevant but often underrecognized components of CD. A GFD may alleviate psychological distress but does not fully eliminate psychiatric morbidity, supporting the need for routine mental health screening and multidisciplinary care.
- 5 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 53, 70252
Open AccessDepression and Anxiety as Aspects of Mental Health in Celiac Disease: A Systematic Review and Meta-Analytical Synthesis
Background:Celiac disease (CD) is a chronic immune-mediated disorder with significant extraintestinal manifestations, including neuropsychiatric symptoms. Depression and anxiety are among the most frequently reported and may substantially affect quality of life. Aim:This review aimed to evaluate the prevalence of depressive and anxiety symptoms in adults and children with CD and to assess the influence of adherence to a GFD on psychiatric outcomes. Material and Methods:A structured narrative review with meta-analytical synthesis was conducted using studies identified through PubMed/MEDLINE, Scopus, and Web of Science. Observational studies, clinical cohorts, and existing meta-analyses were included. Findings were integrated narratively, considering age, disease status, and dietary adherence. Results:Depressive symptoms were consistently more prevalent in individuals with CD, particularly in untreated or newly diagnosed patients. Partial improvement was observed following initiation of a gluten-free diet although symptoms often persisted. Findings regarding anxiety were heterogeneous. Psychiatric outcomes were influenced by disease activity, age, nutritional status, and psychosocial factors. Conclusions:Depression and anxiety are clinically relevant but often underrecognized components of CD. A GFD may alleviate psychological distress but does not fully eliminate psychiatric morbidity, supporting the need for routine mental health screening and multidisciplinary care.
- Open Access
- 4 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 53
The Impact of Repetitive Head Microtrauma on Cognitive Functions in Amateur Athletes – A Narrative Review
Repetitive head impacts (RHI) represent an important and often underestimated risk factor for impaired brain function in individuals participating in contact sports, including amateur athletes. Although they often do not result in clinically diagnosed concussions, research shows that even sub-concussive impacts can lead to measurable changes in brain structure and function, including alterations in white matter integrity and neural connectivity. Their cumulative nature plays a key role, as repeated low-intensity impacts may trigger processes such as axonal injury and neuroinflammation, which can develop gradually and remain undetected in standard clinical assessments. Neuroimaging studies have demonstrated subtle abnormalities even in asymptomatic individuals. These changes have been associated with declines in cognitive functions such as memory, attention, and processing speed, with their severity depending on exposure and individual susceptibility.
- 4 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 53
Open AccessThe Impact of Repetitive Head Microtrauma on Cognitive Functions in Amateur Athletes – A Narrative Review
Repetitive head impacts (RHI) represent an important and often underestimated risk factor for impaired brain function in individuals participating in contact sports, including amateur athletes. Although they often do not result in clinically diagnosed concussions, research shows that even sub-concussive impacts can lead to measurable changes in brain structure and function, including alterations in white matter integrity and neural connectivity. Their cumulative nature plays a key role, as repeated low-intensity impacts may trigger processes such as axonal injury and neuroinflammation, which can develop gradually and remain undetected in standard clinical assessments. Neuroimaging studies have demonstrated subtle abnormalities even in asymptomatic individuals. These changes have been associated with declines in cognitive functions such as memory, attention, and processing speed, with their severity depending on exposure and individual susceptibility.
- Open Access
- 29 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 53
Nordic Walking and Functional Outcomes After Total Knee Arthroplasty
Awareness regarding the impact of prehabilitation and postoperative rehabilitation on recovery after total knee arthroplasty (TKA) has steadily increased in recent years, with growing evidence highlighting their essential role in improving functional outcomes, mobility, and quality of life. Contemporary medical guidelines emphasize not only the importance of structured rehabilitation programs but also the need for individualized therapeutic approaches that consider patients as unique units requiring tailored interventions rather than homogeneous groups. Despite the well-established benefits of conventional rehabilitation strategies, many patients continue to experience limitations in muscle strength, gait performance, and physical activity levels following surgery. In this context, there is an increasing interest in identifying safe, accessible, and effective forms of physical activity that can complement standard rehabilitation protocols. This narrative review aims to examine current evidence on Nordic walking as a potential intervention supporting functional recovery in patients after TKA. Nordic walking, characterized by the use of poles engaging both upper and lower extremities, has been shown to improve cardiovascular fitness, muscular activation, balance, and overall functional capacity in various populations. Its low-impact nature and potential to enhance gait mechanics and stability suggest that it may be particularly suitable for individuals recovering from knee arthroplasty. Although direct evidence in TKA populations remains limited, the physiological and biomechanical benefits observed in other groups indicate that Nordic walking may represent a promising adjunct to rehabilitation programs. Further research is warranted to determine its effectiveness and to establish evidence-based recommendations for its integration into postoperative care.
- 29 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 53
Open AccessNordic Walking and Functional Outcomes After Total Knee Arthroplasty
Awareness regarding the impact of prehabilitation and postoperative rehabilitation on recovery after total knee arthroplasty (TKA) has steadily increased in recent years, with growing evidence highlighting their essential role in improving functional outcomes, mobility, and quality of life. Contemporary medical guidelines emphasize not only the importance of structured rehabilitation programs but also the need for individualized therapeutic approaches that consider patients as unique units requiring tailored interventions rather than homogeneous groups. Despite the well-established benefits of conventional rehabilitation strategies, many patients continue to experience limitations in muscle strength, gait performance, and physical activity levels following surgery. In this context, there is an increasing interest in identifying safe, accessible, and effective forms of physical activity that can complement standard rehabilitation protocols. This narrative review aims to examine current evidence on Nordic walking as a potential intervention supporting functional recovery in patients after TKA. Nordic walking, characterized by the use of poles engaging both upper and lower extremities, has been shown to improve cardiovascular fitness, muscular activation, balance, and overall functional capacity in various populations. Its low-impact nature and potential to enhance gait mechanics and stability suggest that it may be particularly suitable for individuals recovering from knee arthroplasty. Although direct evidence in TKA populations remains limited, the physiological and biomechanical benefits observed in other groups indicate that Nordic walking may represent a promising adjunct to rehabilitation programs. Further research is warranted to determine its effectiveness and to establish evidence-based recommendations for its integration into postoperative care.
- Open Access
- 28 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 53
The Effects of Mindfulness-Based Interventions on Mental Health, Quality of Life, and Physical Activity in Cancer Patients: A Literature Review
Cancer is a major burden in both the somatic and psychological dimensions. Oncology patients often experience high levels of stress, anxiety, depression, and reduced quality of life resulting from both the diagnosis itself and the course of treatment. In recent years, growing attention has been paid to psychosocial interventions that help patients cope with these difficulties. One such approach is mindfulness-based interventions (MBIs), including programs such as Mindfulness-Based Stress Reduction (MBSR). The aim of this paper was to review the literature on the impact of mindfulness-based interventions on mental health, quality of life, and physical activity among cancer patients.
- 28 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 53
Open AccessThe Effects of Mindfulness-Based Interventions on Mental Health, Quality of Life, and Physical Activity in Cancer Patients: A Literature Review
Cancer is a major burden in both the somatic and psychological dimensions. Oncology patients often experience high levels of stress, anxiety, depression, and reduced quality of life resulting from both the diagnosis itself and the course of treatment. In recent years, growing attention has been paid to psychosocial interventions that help patients cope with these difficulties. One such approach is mindfulness-based interventions (MBIs), including programs such as Mindfulness-Based Stress Reduction (MBSR). The aim of this paper was to review the literature on the impact of mindfulness-based interventions on mental health, quality of life, and physical activity among cancer patients.
- Open Access
- 19 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 53, 69812
From Molecular Mechanisms to Functional Outcomes: How Anesthesia Type Affects Postoperative Recovery and Return to Physical Activity
Introduction Anesthetic management plays a central role not only in ensuring intraoperative safety but also in shaping postoperative recovery, including the return to physical and sports activities. Surgical procedures induce a complex neuroendocrine, metabolic, and immune stress response that may influence tissue regeneration and functional recovery. Different anesthetic and analgesic strategies can modulate this response, raising the question of whether the type of anesthesia affects both early recovery and long-term return to physical activity, particularly in physically active individuals and athletes. Materials and Methods This review was based exclusively on publications available in PubMed, PMC, and related scientific databases. The analyzed studies included retrospective, clinical, and comparative investigations, as well as narrative and review articles. The research focused on the impact of anesthesia type (general, regional, spinal, and combinations thereof) on postoperative functional outcomes. These outcomes assessed in the reviewed studies included isokinetic muscle strength testing, pain intensity, recovery quality scores (e.g., QoR-40), early mobilization parameters, and selected indicators of physiological stress response. Statistical analyses in the cited studies included methods such as analysis of variance (ANOVA) to compare recovery outcomes between anesthetic techniques. Literature Review The reviewed literature suggests that the type of anesthesia may influence early postoperative parameters, including pain control, hemodynamic stability, adverse effect profile, and early quality of recovery. However, evidence regarding its impact on long-term return to physical activity is less consistent. In patients undergoing anterior cruciate ligament (ACL) reconstruction, no significant differences in muscle strength recovery were observed six months postoperatively between different anesthetic techniques. Similarly, studies comparing regional and general anesthesia using QoR-40 scores found no significant differences in global recovery quality, despite improved analgesia with regional techniques. Comparisons between total intravenous anesthesia (TIVA) and inhalational anesthesia demonstrated differences in emergence time, postoperative nausea and vomiting, and early recovery quality, but their influence on long-term exercise capacity remains unclear. Early mobilization interventions did not consistently increase overall physical activity during the first postoperative days, underscoring the multifactorial nature of postoperative recovery. Summary and Conclusions The impact of anesthesia type on return to physical activity after surgery is complex and influenced by multiple interacting factors. While anesthetic technique may affect early recovery parameters such as pain intensity, adverse effects, and quality of emergence current evidence does not consistently demonstrate a direct effect on long-term physical performance or exercise capacity. Full return to activity appears to depend on the combined influence of surgical factors, stress response modulation, effective pain management, rehabilitation strategies, and individual patient characteristics.
- 19 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 53, 69812
Open AccessFrom Molecular Mechanisms to Functional Outcomes: How Anesthesia Type Affects Postoperative Recovery and Return to Physical Activity
Introduction Anesthetic management plays a central role not only in ensuring intraoperative safety but also in shaping postoperative recovery, including the return to physical and sports activities. Surgical procedures induce a complex neuroendocrine, metabolic, and immune stress response that may influence tissue regeneration and functional recovery. Different anesthetic and analgesic strategies can modulate this response, raising the question of whether the type of anesthesia affects both early recovery and long-term return to physical activity, particularly in physically active individuals and athletes. Materials and Methods This review was based exclusively on publications available in PubMed, PMC, and related scientific databases. The analyzed studies included retrospective, clinical, and comparative investigations, as well as narrative and review articles. The research focused on the impact of anesthesia type (general, regional, spinal, and combinations thereof) on postoperative functional outcomes. These outcomes assessed in the reviewed studies included isokinetic muscle strength testing, pain intensity, recovery quality scores (e.g., QoR-40), early mobilization parameters, and selected indicators of physiological stress response. Statistical analyses in the cited studies included methods such as analysis of variance (ANOVA) to compare recovery outcomes between anesthetic techniques. Literature Review The reviewed literature suggests that the type of anesthesia may influence early postoperative parameters, including pain control, hemodynamic stability, adverse effect profile, and early quality of recovery. However, evidence regarding its impact on long-term return to physical activity is less consistent. In patients undergoing anterior cruciate ligament (ACL) reconstruction, no significant differences in muscle strength recovery were observed six months postoperatively between different anesthetic techniques. Similarly, studies comparing regional and general anesthesia using QoR-40 scores found no significant differences in global recovery quality, despite improved analgesia with regional techniques. Comparisons between total intravenous anesthesia (TIVA) and inhalational anesthesia demonstrated differences in emergence time, postoperative nausea and vomiting, and early recovery quality, but their influence on long-term exercise capacity remains unclear. Early mobilization interventions did not consistently increase overall physical activity during the first postoperative days, underscoring the multifactorial nature of postoperative recovery. Summary and Conclusions The impact of anesthesia type on return to physical activity after surgery is complex and influenced by multiple interacting factors. While anesthetic technique may affect early recovery parameters such as pain intensity, adverse effects, and quality of emergence current evidence does not consistently demonstrate a direct effect on long-term physical performance or exercise capacity. Full return to activity appears to depend on the combined influence of surgical factors, stress response modulation, effective pain management, rehabilitation strategies, and individual patient characteristics.
- Open Access
- 17 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 51
Evening Primrose Oil (Oenothera biennis L.) in Women’s Health: A Narrative Review of Clinical Evidence
Evening primrose oil (EPO), derived from the seeds of Oenothera biennis L., has been widely used as a complementary therapeutic agent in various female health conditions. Its biological activity is primarily attributed to its high content of essential omega-6 fatty acids, particularly linoleic acid and γ-linolenic acid, which serve as precursors of anti-inflammatory prostaglandins. Over recent decades, increasing clinical interest has focused on the potential role of EPO in the management of premenstrual syndrome, mastalgia, menopausal symptoms, polycystic ovary syndrome, and other inflammatory or hormone-related disorders affecting women. The present narrative review aims to summarize current evidence regarding the phytochemical composition, proposed mechanisms of action, clinical efficacy, and safety profile of evening primrose oil in women’s health. A comprehensive literature search of electronic databases was conducted, including randomized controlled trials, systematic reviews, meta-analyses, and observational studies. Available evidence suggests that evening primrose oil may provide symptomatic relief in selected conditions, particularly mastalgia and certain menopausal symptoms, while results in premenstrual syndrome and other indications remain inconsistent. Overall, EPO appears to be well tolerated, although its therapeutic effectiveness varies depending on dosage, duration of use, and clinical indication. Further large-scale, well-designed clinical trials are required to establish clear recommendations for its use in general medical practice.
- 17 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 51
Open AccessEvening Primrose Oil (Oenothera biennis L.) in Women’s Health: A Narrative Review of Clinical Evidence
Evening primrose oil (EPO), derived from the seeds of Oenothera biennis L., has been widely used as a complementary therapeutic agent in various female health conditions. Its biological activity is primarily attributed to its high content of essential omega-6 fatty acids, particularly linoleic acid and γ-linolenic acid, which serve as precursors of anti-inflammatory prostaglandins. Over recent decades, increasing clinical interest has focused on the potential role of EPO in the management of premenstrual syndrome, mastalgia, menopausal symptoms, polycystic ovary syndrome, and other inflammatory or hormone-related disorders affecting women. The present narrative review aims to summarize current evidence regarding the phytochemical composition, proposed mechanisms of action, clinical efficacy, and safety profile of evening primrose oil in women’s health. A comprehensive literature search of electronic databases was conducted, including randomized controlled trials, systematic reviews, meta-analyses, and observational studies. Available evidence suggests that evening primrose oil may provide symptomatic relief in selected conditions, particularly mastalgia and certain menopausal symptoms, while results in premenstrual syndrome and other indications remain inconsistent. Overall, EPO appears to be well tolerated, although its therapeutic effectiveness varies depending on dosage, duration of use, and clinical indication. Further large-scale, well-designed clinical trials are required to establish clear recommendations for its use in general medical practice.
- Open Access
- 14 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 51
The role of ginger (Zingiber officinale) in the management of nausea and vomiting
Nausea and vomiting are common and clinically relevant symptoms associated with a wide range of medical conditions, including chemotherapy and radiotherapy, surgical procedures, pregnancy, and gastrointestinal disorders. Their pathophysiology involves complex interactions between central and peripheral nervous system pathways, neurotransmitters, inflammatory mediators, and gastrointestinal motility. Ginger (Zingiber officinale), a medicinal plant traditionally used to alleviate gastrointestinal discomfort, contains bioactive compounds such as gingerols and shogaols that exhibit anti-inflammatory, prokinetic, and neuro-modulatory properties. This article provides a narrative review of current clinical and experimental evidence regarding the role of ginger in the management of nausea and vomiting, with particular emphasis on chemotherapy-induced nausea and vomiting, postoperative nausea, nausea of pregnancy, and selected gastrointestinal conditions.
- 14 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 51
Open AccessThe role of ginger (Zingiber officinale) in the management of nausea and vomiting
Nausea and vomiting are common and clinically relevant symptoms associated with a wide range of medical conditions, including chemotherapy and radiotherapy, surgical procedures, pregnancy, and gastrointestinal disorders. Their pathophysiology involves complex interactions between central and peripheral nervous system pathways, neurotransmitters, inflammatory mediators, and gastrointestinal motility. Ginger (Zingiber officinale), a medicinal plant traditionally used to alleviate gastrointestinal discomfort, contains bioactive compounds such as gingerols and shogaols that exhibit anti-inflammatory, prokinetic, and neuro-modulatory properties. This article provides a narrative review of current clinical and experimental evidence regarding the role of ginger in the management of nausea and vomiting, with particular emphasis on chemotherapy-induced nausea and vomiting, postoperative nausea, nausea of pregnancy, and selected gastrointestinal conditions.
- Open Access
- 4 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 51, 68504
The Role of Myo-Inositol in the Management of Metabolic and Reproductive Sequelae of Polycystic Ovary Syndrome: A Comprehensive Review of the Current State of Knowledge
Polycystic Ovary Syndrome (PCOS) represents a heterogeneous and multifaceted endocrinopathy, characterized by extensive metabolic implications, affecting a substantial global cohort of reproductive-age women. Central to its pathogenesis is insulin resistance (IR) and compensatory hyperinsulinemia, which drive both metabolic dysfunction and reproductive failures. Myo-inositol (MI), acting as a vital second messenger for both insulin and follicle-stimulating hormone (FSH), has emerged as a cornerstone therapeutic agent. This comprehensive review evaluates the clinical efficacy of MI, particularly when administered in the physiological 40:1 ratio with D-chiro-inositol (DCI). We analyze its impact on glycemic profiles, hormonal stabilization, and the enhancement of oocyte competence. Based on the 2023 International Evidence-based Guidelines and recent clinical trials, MI represents a safe, well-tolerated, and effective alternative to traditional pharmacological interventions, providing a holistic approach to PCOS management.
- 4 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 51, 68504
Open AccessThe Role of Myo-Inositol in the Management of Metabolic and Reproductive Sequelae of Polycystic Ovary Syndrome: A Comprehensive Review of the Current State of Knowledge
Polycystic Ovary Syndrome (PCOS) represents a heterogeneous and multifaceted endocrinopathy, characterized by extensive metabolic implications, affecting a substantial global cohort of reproductive-age women. Central to its pathogenesis is insulin resistance (IR) and compensatory hyperinsulinemia, which drive both metabolic dysfunction and reproductive failures. Myo-inositol (MI), acting as a vital second messenger for both insulin and follicle-stimulating hormone (FSH), has emerged as a cornerstone therapeutic agent. This comprehensive review evaluates the clinical efficacy of MI, particularly when administered in the physiological 40:1 ratio with D-chiro-inositol (DCI). We analyze its impact on glycemic profiles, hormonal stabilization, and the enhancement of oocyte competence. Based on the 2023 International Evidence-based Guidelines and recent clinical trials, MI represents a safe, well-tolerated, and effective alternative to traditional pharmacological interventions, providing a holistic approach to PCOS management.
- Open Access
- 27 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50
The Role of Curcumin in Obesity: Mechanisms and Metabolic Implications
Obesity is a complex, multifactorial chronic disease associated with metabolic, inflammatory, cardiovascular, renal, and gastrointestinal complications. Increasing interest has been directed toward bioactive dietary compounds with potential anti-obesity properties. Curcumin, the principal polyphenolic compound derived from Curcuma longa, has been extensively investigated for its metabolic, anti-inflammatory, antioxidant, and regulatory effects on adipose tissue, liver metabolism, insulin sensitivity, and gut microbiota. This review summarizes and critically analyzes available evidence regarding the role of curcumin in obesity, drawing on in vitro studies, animal models, clinical trials, and mechanistic investigations. The findings indicate that curcumin supplementation is associated with attenuation of weight gain, adipogenesis, inflammation, insulin resistance, lipid accumulation, and obesity-related organ dysfunction through multiple molecular pathways. However, most available evidence originates from preclinical models, while clinical data remain limited and heterogeneous, highlighting the need for cautious interpretation of translational relevance. Further well-designed, large-scale clinical studies are required to clarify curcumin’s therapeutic potential in obesity management.
- 27 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50
Open AccessThe Role of Curcumin in Obesity: Mechanisms and Metabolic Implications
Obesity is a complex, multifactorial chronic disease associated with metabolic, inflammatory, cardiovascular, renal, and gastrointestinal complications. Increasing interest has been directed toward bioactive dietary compounds with potential anti-obesity properties. Curcumin, the principal polyphenolic compound derived from Curcuma longa, has been extensively investigated for its metabolic, anti-inflammatory, antioxidant, and regulatory effects on adipose tissue, liver metabolism, insulin sensitivity, and gut microbiota. This review summarizes and critically analyzes available evidence regarding the role of curcumin in obesity, drawing on in vitro studies, animal models, clinical trials, and mechanistic investigations. The findings indicate that curcumin supplementation is associated with attenuation of weight gain, adipogenesis, inflammation, insulin resistance, lipid accumulation, and obesity-related organ dysfunction through multiple molecular pathways. However, most available evidence originates from preclinical models, while clinical data remain limited and heterogeneous, highlighting the need for cautious interpretation of translational relevance. Further well-designed, large-scale clinical studies are required to clarify curcumin’s therapeutic potential in obesity management.